发明名称 |
MULTIPLE UNIT DOSAGE FORM OF NIACIN |
摘要 |
A multiple unit dosage form useful for treating or preventing hyperlipidemia and/or atherosclerosis, wherein multiple unit dosage form comprise of a therapeutically effective amount of niacin or its derivatives and one or more control releasing agent(s) and pharmaceutically acceptable excipients, weight percentages are based upon the total weight of the dosage form. The multiple unit dosage form may comprise of optionally other antihyperlipidemic agent, more preferably HMG CoA reductase inhibitor. The most preferable dosage form is capsule. Further a kit comprising one or more capsules co-packaged to provide multiple unit dosage form of niacin or its derivatives in combination with HMG CoA reductase inhibitor is disclosed.
|
申请公布号 |
US2011123609(A1) |
申请公布日期 |
2011.05.26 |
申请号 |
US200913054901 |
申请日期 |
2009.07.16 |
申请人 |
BORUDE SUNIL SHANTWAN;KOLE SHRENIK ANNASAHEB;AVACHAT MAKARAND KRISHNAKUMAR |
发明人 |
BORUDE SUNIL SHANTWAN;KOLE SHRENIK ANNASAHEB;AVACHAT MAKARAND KRISHNAKUMAR |
分类号 |
A61K9/48;A61K31/455;A61P3/06 |
主分类号 |
A61K9/48 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|